# Bortezomib With Melphalan and Prednisone for Multiple Myeloma

> **NCT00734149** · PHASE2 · COMPLETED · sponsor: **Duke University** · enrollment: 45 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Bortezomib
- **DRUG:** Melphalan
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT00734149
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00734149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00734149, "Bortezomib With Melphalan and Prednisone for Multiple Myeloma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00734149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*